TY - JOUR
T1 - CCR2-dependent recruitment of Tregs and monocytes following radiotherapy is associated with TNFa-mediated resistance
AU - Mondini, Michele
AU - Loyher, Pierre Louis
AU - Hamon, Pauline
AU - de Thore, Marine Gerbe
AU - Laviron, Marie
AU - Berthelot, Kevin
AU - Clemenson, Celine
AU - Salomon, Benoit L.
AU - Combadiere, Christophe
AU - Deutsch, Eric
AU - Boissonnas, Alexandre
N1 - Publisher Copyright:
©2019 American Association for Cancer Research.
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Radiotherapy (RT) represents one of the main anti-accumulation of tumor necrosis factor alpha (TNFa)-pro-cancer approaches for the treatment of solid tumors. ducing monocytes and CCR2 þ regulatory T cells (Treg). Beyond the expected direct effects of RT on tumor cells, This corecruitment was associated with a TNFa-dependent evidence supporting the importance of an immune activation of Tregs, dampening the efficacy of RT. Our response to RT is growing. The balance between RT-medi-results highlight an unexpected cross-talk between innate ated immunogenic and tolerogenic activity is ill-defined and adaptive immune system components and indicate and deserves more attention. Herein, a murine model of CCL2/CCR2 and TNFa as potential clinical candidates to head and neck squamous cell carcinoma was used to counterbalance the radioprotective action of monocyte-demonstrate that RT upregulated CCL2 chemokine pro-derived cells and Tregs, paving the way for potent com-duction in tumor cells, leading to a CCR2-dependent bined radioimmunotherapies.
AB - Radiotherapy (RT) represents one of the main anti-accumulation of tumor necrosis factor alpha (TNFa)-pro-cancer approaches for the treatment of solid tumors. ducing monocytes and CCR2 þ regulatory T cells (Treg). Beyond the expected direct effects of RT on tumor cells, This corecruitment was associated with a TNFa-dependent evidence supporting the importance of an immune activation of Tregs, dampening the efficacy of RT. Our response to RT is growing. The balance between RT-medi-results highlight an unexpected cross-talk between innate ated immunogenic and tolerogenic activity is ill-defined and adaptive immune system components and indicate and deserves more attention. Herein, a murine model of CCL2/CCR2 and TNFa as potential clinical candidates to head and neck squamous cell carcinoma was used to counterbalance the radioprotective action of monocyte-demonstrate that RT upregulated CCL2 chemokine pro-derived cells and Tregs, paving the way for potent com-duction in tumor cells, leading to a CCR2-dependent bined radioimmunotherapies.
UR - http://www.scopus.com/inward/record.url?scp=85062286093&partnerID=8YFLogxK
U2 - 10.1158/2326-6066.CIR-18-0633
DO - 10.1158/2326-6066.CIR-18-0633
M3 - Article
C2 - 30696630
AN - SCOPUS:85062286093
SN - 2326-6066
VL - 7
SP - 376
EP - 387
JO - Cancer Immunology Research
JF - Cancer Immunology Research
IS - 3
ER -